China Universal Asset Management Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
GA
VF
WCM
China Universal Asset Management Company's REGN Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Regeneron Pharmaceuticals (REGN) stake by 8.7% in Q2 2026, selling an estimated $1.27M and leaving 19,498 shares worth $12.2M. The position accounts for 0.73% of the portfolio, ranked #33.
China Universal Asset Management Company first reported a position in REGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $17.6M in Q4 2024. 393 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- China Universal Asset Management Company held 19,498 shares of Regeneron Pharmaceuticals worth $12.2M as of Q2 2026.
- China Universal Asset Management Company sold 1,863 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.27M.
- Regeneron Pharmaceuticals made up 0.73% of China Universal Asset Management Company's portfolio in Q2 2026, its #33 holding.
- China Universal Asset Management Company first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Regeneron Pharmaceuticals position peaked at $17.6M in Q4 2024.
- 393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.